Correlation Between Revolution Medicines and Day One
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Revolution Medicines and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Day One.
Diversification Opportunities for Revolution Medicines and Day One
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Revolution and Day is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Day One go up and down completely randomly.
Pair Corralation between Revolution Medicines and Day One
Given the investment horizon of 90 days Revolution Medicines is expected to generate 0.9 times more return on investment than Day One. However, Revolution Medicines is 1.12 times less risky than Day One. It trades about 0.35 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest 4,775 in Revolution Medicines on August 28, 2024 and sell it today you would earn a total of 975.00 from holding Revolution Medicines or generate 20.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Revolution Medicines vs. Day One Biopharmaceuticals
Performance |
| Timeline |
| Revolution Medicines |
| Day One Biopharmaceu |
Revolution Medicines and Day One Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revolution Medicines and Day One
The main advantage of trading using opposite Revolution Medicines and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.| Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
| Day One vs. Eliem Therapeutics | Day One vs. HCW Biologics | Day One vs. Scpharmaceuticals | Day One vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |